Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
O
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Price:
5 890
KRW
0.86%
Market Closed
Market Cap:
₩104B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
KR |
|
B
|
Brightview Holdings Inc
NYSE:BV
|
US |
|
ITAB Shop Concept AB
STO:ITAB
|
SE |
|
A
|
ADTechnology Co Ltd
KOSDAQ:200710
|
KR |
|
Yoshicon Co Ltd
TSE:5280
|
JP |
|
Energy Action Ltd
ASX:EAX
|
AU |
|
Volati AB
F:VOG
|
SE |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Optus Pharmaceutical Co Ltd's stock price target?
Not Available
Optus Pharmaceutical Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Optus Pharmaceutical Co Ltd?
Projected CAGR
-20%
-20%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next -8 years is -20%.
What is the Gross Profit forecast for Optus Pharmaceutical Co Ltd?
Projected CAGR
-21%
-21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next -8 years is -21%.
What is the Operating Income forecast for Optus Pharmaceutical Co Ltd?
Projected CAGR
-30%
-30%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next -8 years is -30%.
What is the Pre-Tax Income forecast for Optus Pharmaceutical Co Ltd?
Projected CAGR
-28%
-28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next -8 years is -28%.
What is the Net Income forecast for Optus Pharmaceutical Co Ltd?
Projected CAGR
-27%
-27%
Over the last 13 years, the compound annual growth rate for Net Income has been 18%. The projected CAGR for the next -8 years is -27%.